Matinas BioPharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The firm's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. 

CEO
Jerome D. Jabbour
CEOJerome D. Jabbour
Employees
31
Employees31
Headquarters
Bedminster, New Jersey
HeadquartersBedminster, New Jersey
Founded
2013
Founded2013
Employees
31
Employees31

MTNB Key Statistics

Market cap
126.65M
Market cap126.65M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
339.30K
Average volume339.30K
High today
$0.6299
High today$0.6299
Low today
$0.5602
Low today$0.5602
Open price
$0.6299
Open price$0.6299
Volume
1.33M
Volume1.33M
52 Week high
$1.16
52 Week high$1.16
52 Week low
$0.49
52 Week low$0.49

MTNB Earnings

-$0.03
-$0.02
-$0.01
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 8, After Hours
ActualExpected Mar 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.